SEARCH
Enter your search term below:
SEARCH RESULTS
Your search for '' returned results, displayed below.
Refine your search term or search again:
2141
ESA or UKSA? Choosing the right funding partner for your innovation
Blog | SETsquared Editor | Mon, 07/07/2025 | 14:34
For early-stage UK space tech ventures, understanding where and how to access public funding is critical to accelerating development. Two of the most influential actors in this space are the European Space Agency (ESA) and the UK Space Agency (UKSA). While both support innovation across the space ecosystem, they operate differently with distinct...
mytender.io announce £250,000 pre-seed raise
News | Nikita Troughton | Thu, 03/07/2025 | 14:32
mytender.io (Future Worlds Cohort 25) has announced a £250,000 pre-seed fundraise, the largest investment so far for a startup founded by current undergraduates at the University of Southampton. The investment was led by Fuel Ventures and was the fastest deal close the firm has ever made. Co-founded by current University of...
SETsquared start-ups capture corporate VC spotlight at Global Corporate Venturing Symposium
News | Emma Blunt | Wed, 25/06/2025 | 11:49
Innovative ventures showcase breakthrough tech to corporate investors as CVC funding surges A cohort of high-growth start-ups supported by SETsquared recently took centre stage at the Global Corporate Venturing (GCV) Symposium, Europe’s premier event for corporate innovation and venture investment, which brings together 350+ attendees from across 26 countries. Bringing together...
Ceryx Medical secures $15m to advance groundbreaking heart failure technology
News | Emma Blunt | Wed, 25/06/2025 | 11:30
University of Bath and Bristol spin-out, Ceryx Medical, a UK-based medtech innovator developing next-generation bioelectronic therapies for heart failure, has announced the successful closure of a new funding round, bringing the company’s total raised to $15 million. The investment marks a major milestone in Ceryx’s mission to revolutionise cardiac care...
Draig Therapeutics secures $140 million investment in new therapies for neuropsychiatric disorders
News | Nikita Troughton | Thu, 19/06/2025 | 14:09
Cardiff University spin-out Draig Therapeutics is putting Welsh research at the centre of pioneering new therapies for neuropsychiatric disorders as part of a multi-million pound investment. The new spinout will launch as a clinical-stage company with a $140 million (£107 million) investment from leading international venture investors to advance the development of...
